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ImmunohistochemistryA remarkable feature of neuronal glutamate transporters (EAATs) is their dual functions of classical
carriers and ligand-gated chloride (Cl) channels. Cl conductance is rapidly activated by glutamate in
subtype EAAT5, which mediates light responses in depolarizing bipolar cells (DBC) in retinae of lower
vertebrates. In this study, we examine whether EAAT5 also mediates the DBC light response in mouse.
We took advantage of an infrared illuminated micro-injection system, and studied the effects of the EAAT
blocker (TBOA) and a glutamate receptor agonist (LAP4) on the mouse electroretinogram (ERG) b-wave
responses. Our results showed that TBOA and LAP4 shared similar temporal patterns of inhibition: both
inhibited the ERG b-wave shortly after injection and recovered with similar time courses. TBOA inhibited
the b-wave completely at mesopic light intensity with an IC50 value about 1 log unit higher than that of
LAP4. The inhibitory effects of TBOA and LAP4 were found to be additive in the photopic range. Further-
more, TBOA alone inhibited the b-wave in the cone operative range in knockout mice lacking DBCRs at a
low concentration that did not alter synaptic glutamate clearance activity. It also produced a stronger
inhibition than that of LAP4 on the cone-driven b-wave measured with a double ﬂash method in wildtype
mice. These electrophysiological data suggest a signiﬁcant role for EAAT5 in mediating cone-driven DBC
light responses. Our immunohistochemistry data indicated the presence of postsynaptic EAAT5 on some
DBCCs and some DBCRs, providing an anatomical basis for EAAT5’s role in DBC light responses.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
The amino acid L-glutamate is the major retinal excitatory
transmitter that is used by the ﬁrst synapse between photorecep-
tors and second-order retinal neurons (Massey, 1990; Massey &
Redburn, 1987). In darkness, L-glutamate (GLU) is continuouslyreleased from axonal terminals of cone and rod photoreceptors
(Copenhagen & Jahr, 1989). Light hyperpolarizes photoreceptors
and decreases vesicular GLU release, suppresses GLU binding with
postsynaptic GLU receptors, and changes bipolar and horizontal
cell responses (Attwell, 1990; Cervetto & MacNichol, 1972;
Murakami, et al., 1975). The membrane potentials in the bipolar
and horizontal cells are largely determined by the concentration
of GLU in the synaptic cleft, so it is critical to precisely control
the amount of GLU in the cleft to ensure reliable transmission of
light elicited signal. This is achieved by GLU uptake by excitatory
amino acid transporters (EAATs). To date, ﬁve subtypes of EAATs
have been identiﬁed in the mammalian central nervous system
(Danbolt, 2001; Shigeri, et al., 2004), named EAAT1 to EAAT5.
A remarkable observation of EAATs is their dual functions of
classical carriers and ligand-gated chloride (Cl) channels
(reviewed by (Sonders & Amara, 1996)). Brieﬂy, some EAATs were
found to mediate substrate-elicited currents exceeding that pre-
dicted for coupling stoichiometry, to a magnitude comparable to
a bona ﬁde ion channel. More interestingly, some variants of the
transporters have been shown to mediate currents without
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glutamate and dependent on sodium ions, was reported to be more
pronounced in EAAT5 (Arriza, et al., 1997) in contrast to the small
but measurable conductance associated with the other EAATs
(Wadiche, et al., 1995). In retina, such Cl conductance has been
demonstrated in terminals of salamander (Grant & Werblin,
1996; Sarantis, et al., 1988), turtle (Tachibana & Kaneko, 1988a),
mouse (Hasegawa, et al., 2006) and ground squirrel photoreceptors
(Szmajda & Devries, 2011), as well as teleost (Grant & Dowling,
1995, 1996) and mouse bipolar cells (Wersinger, et al., 2006), sug-
gesting a possible role in regulating presynaptic endogenous GLU
release. Most interestingly, EAAT5 has been shown to act as a
postsynaptic receptor and mediate light responses in teleost bipo-
lar cells through its associated chloride conductance (Grant &
Dowling, 1995, 1996; Nelson & Singla, 2009; Wong, et al., 2005a;
Wong, et al., 2005b), implying that the GLU-gated EAAT5 channels
may play a signiﬁcant role in the ON pathway in the retina.
It is believed that the postsynaptic mechanism mediating light
responses depends on the group III metabotropic glutamate recep-
tor mGluR6 on depolarizing bipolar cells in mammal (Nakajima,
et al., 1993). In human, mutations in the gene encoding mGluR6
lead to night blindness (Dryja, et al., 2005). Affected patients are
blind under scotopic condition but have near-normal visual acuity
and limited degradation of visual function under photopic lighting
condition. Their electroretinograms showed no rod-driven b-wave
but partially preserved cone b-wave. Similarly, mGluR6 deﬁciency
in mouse eliminated b-wave and resulted in a negative ERG in the
rod operative range (Masu, et al., 1995). Interesting, a minor
corneal-positive component was also shown in the ERGs under
the photopic range at around 50 ms (see Fig. 4D of the Masu
et al. paper) and the behavioral test result was normal. Similar cor-
neal-positive component has been found in our preliminary results
at 40–50 ms (unpublished observation). The above ﬁndings could
be partly explained if there are other glutamate receptors on the
depolarizing bipolar cells besides mGluR6.
To test the above hypothesis and determine whether EAAT5
mediates the light response of depolarizing bipolar cells (DBC) in
dark-adapted mouse retina, we took advantage of an infrared illu-
minated micro-injection system to apply GLU analogue and EAAT5
blocker shortly before the scotopic ERG b-wave (which originates
from DBCs) was measured. The time course and dose–response
relations of those drugs are also reported. Finally, we veriﬁed our
electrophysiological ﬁndings with anatomical evidence by localiz-
ing EAAT5 in mouse retina using immunohistochemistry (IHC).2. Material and methods
2.1. Animals
Ninety-three Wildtype (WT) mice (C57BL/6) from Jackson
Laboratories (Bar Harbor, ME) and 7 Bhlhb4(/) mice (99%
C57BL/6 genetic background) (Bramblett, et al., 2004) between 8
and 12 weeks old were used for experiments. Animals were treated
in accordance with NIH guidelines and the Baylor College of
Medicine IACUC welfare guidelines.2.2. Intravitreal injection
Solutions containing LAP4 (Cat. no. 0103, Tocris bioscience,
Minneapolis, MN), or TBOA (Cat. no. 1223, Tocris bioscience) were
prepared by dissolving them in sterile Balanced Salt Solution
(Alcon, Fort Worth, TX). Retinal concentrations of drugs were
calculated assuming injected solution was diluted by 20 lL of
vitreous.Prior to injection, mice were ﬁrst allowed to adapt to the dark
for a minimum of 4 h. Under dim red light, mice were anaesthe-
tized with weight-based intraperitoneal injection of solution con-
taining ketamine (46 mg/ml), xylazine (9.2 mg/ml), and
acepromazine (0.77 mg/ml). A single drop of 1% tropicamide,
2.5% phenylephrine and 0.5% proparacaine hydrochloride were
instilled on the cornea to dilate the pupil and for topical anesthesia.
Under infrared illumination, a 32-gauge disposable needle was
used to puncture the sclera. Drug containing solution, or control
saline solution, was injected unilaterally using a NanoFil microin-
jection system (World Precision Instrument, FL) into the vitreous
chamber with a 34-gauge blunt needle visible through the dilated
pupil. To prevent the injected solution from escaping the eye when
the needle was withdrawn, the needle was allowed to stay for an
additional 30 s in the eye following the displacement of the
plunger.
2.3. Electroretinogram
Mice were placed inside a Ganzfeld dome coated with highly
reﬂective white paint (Munsell Paint, NewWindsor, NY) with their
body temperature maintained at 39 C using a heating pad. A
blunt platinum active needle electrode was placed in contact with
the center of each cornea. A small amount of 2.5% methylcellulose
gel was applied to the eye. Reference and ground electrodes
were respectively placed in the forehead and tail. Mice were
then allowed to remain in complete darkness for 3 min before
recording.
A half millisecond square pulse of 505 nm peak wavelength,
generated using cyan light emitting diodes, was used for all scoto-
pic stimuli. To facilitate dissection of the rod and cone pathways,
the scotopic ERG protocol which was comprised of progressively
increasing stimuli strength, was used to measure the b- and
a-waves in different zones as deﬁned previously (Abd-El-Barr,
et al., 2009). At the lowest intensity, 25 responses were averaged
with a delay of 2 s between each ﬂash. As the intensity of the ﬂash
increased, fewer responses were averaged with a longer delay
between ﬂashes. At the end of the scotopic protocol, saturating
stimuli were generated with 1500W xenon ﬂash bulbs (Novatron,
Dallas, TX), attenuated with apertures and diffusers. The above
protocol lasted 11 min and was implemented 4 times in the ﬁrst
hours following injection of the drugs to study the time course of
their effects.
The cone ERG was studied by a double-ﬂash method using the
xenon ﬂashes. An initial conditioning ﬂash saturates both rods
and cones 2 s before a probe ﬂash. The ERG recorded by the probe
ﬂash is attributed to responses driven by the cones. All ﬂashes
were calibrated with a photometer (ILT1700 International Light,
MA) and converted to the unit photoisomerizations/rod (R*/Rod),
where 1 scot cd m2 = 581 photoisomerizations/rod/s (Lyubarsky,
et al., 2004; Saszik, et al., 2002). Signals were ampliﬁed with a
Grass P122 ampliﬁer (band-pass 0.1–1000 Hz; Grass Instruments,
West Warwick, RI). Data were acquired at a sampling rate of
10 kHz with a data acquisition board (USB-6216, National Instru-
ments, TX). Traces were averaged and analyzed with custom codes
written in Matlab (The MathWorks, Natick, MA). To remove oscil-
latory potentials before ﬁtting, the scotopic b-wave was digitally
ﬁltered using the ﬁltﬁlt function (low-pass ﬁltered; Fc = 60 Hz) in
Matlab. Dose–response curves showing b-wave against drug con-
centration were ﬁtted using the DoseRep function of OriginPro
v8.6 (OriginLab Corp., Northampton, MA) pharmacology toolbox.
Statistical comparison between groups in this paper was calculated
using a 2 tailed t-test or one-way ANOVA with Tukey post hoc test,
and signiﬁcant difference was deﬁned as p < 0.05 unless otherwise
stated.
Table 1
Primary antibodies/lectin used in this study.
Antigen Dilution Host, type Source Catalog no. Immunogen
Calbindin 1:1000 Rabbit, polyclonal Millipore (Billerica, MA) AB1778 Recombinant mouse calbindin
EAAT5 1:20 Goat, polyclonal Santa Cruz Biotechnology (Santa Cruz, CA) sc-18779 Peptide corresponding to amino acid 150–220
from an internal region of human EAAT5
Goa 1:500 Mouse, monoclonal Chemicon International (Temecula, CA) MAB3073 Puriﬁed bovine brain Goa
PKCa 1:1000 Rabbit, polyclonal Sigma–Aldrich Co. LLC (St. Louis, MO) P4334 Synthetic peptide corresponding to amino acids 659–672
from the C-terminal variable (V5) region of rat PKCa
1:250 Mouse, monoclonal BD Transduction Lab. (San Jose, CA) 610107 Human PKCa aa. 270–427 recombinant protein
PSD95 1:100 Rabbit, polyclonal Abcam plc (Cambridge, MA) Ab18258 Synthetic peptide conjugated to KLH derived from
within residues 50–150 of Mouse PSD95
Peanut
agglutinin
1:50 – Vector Laboratories Inc. (Burlingame, CA) FL-1071 –
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The following antibodies were obtained from commercial sup-
pliers and applied in order to label speciﬁc cell types of the retina
(Table 1). Horizontal cells were immuno-labeled with a mouse
monoclonal antibody against calbindin (de Melo, et al., 2003).
ON-cone and rod bipolar cells were immuno-labeled with a
mouse monoclonal antibody against G-protein Goa (Haverkamp
& Wassle, 2000). Rod bipolar cells were immuno-labeled with
rabbit and mouse antibodies against PKCa (Zhang, et al., 2005).
Rod photoreceptor spherules were labeled with anti-PSD95
antibody (Oh, et al., 2007). Fluorescein tagged peanut agglutinin
(PNA) was used to stain cone pedicles (Blanks & Johnson, 1983).
Anti-EAAT5 antiserum was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA) for labeling membrane EAAT5.
The antiserum has been shown to label rod spherules, cone
pedicles, some amacrine and some bipolar cells (Fyk-Kolodziej,
et al., 2004) in the cat retina. The speciﬁcity of the antiserum
has been veriﬁed by Western blots of retina which showed the
immunoreactivity to be concentrated in a single band, at the
published molecular weight of 63 kD (Pow & Barnett, 2000), that
reduced greatly when pre-incubated with blocking peptide
(Fyk-Kolodziej, et al., 2004).
2.5. Tissue preparation and immunohistochemistry
The eyes were enucleated when the mice were deeply anesthe-
tized, just before they were euthanized by an overdose of the anes-
thesia. The eyes were then dissected and the whole retina was
isolated carefully. The whole retinae were ﬁxed in 4% paraformal-
dehyde (Electron Microscopy Science, Fort Washington, PA) in
phosphate buffer (DPBS, Invitrogen, La Jolla, CA), pH 7.4, for
45 min at room temperature.
IHC was performed using an indirect antibody method. The ret-
inae were blocked with 10% donkey serum (Jackson Immunore-
search, West Grove, PA) in TBS (DPBS with 0.5% Triton X-100
(Sigma) and 0.1% sodium azide (Sigma), pH 7.2) at 4 C overnight
to decrease non-speciﬁc labeling. Blocked retinae were cut into
vertical sections 40 lm in thickness using a vibratome, and the
free-ﬂoating sections were incubated in primary antibodies in
the presence of 3% donkey serum-TBS for 4 days at 4 C. Controls
lacking primary antibodies were also processed. After rinsing sev-
eral times, the sections were transferred into donkey-hosted sec-
ondary antibodies conjugated with Cy5, Cy3 (1:200, Jackson
Immunoresearch), or Alexa Fluor 488 (1:200, Molecular Probes,
Eugene, OR) in 3% normal donkey serum-TBS solution at 4 C over-
night. Following several rinses, the sections were mounted with
Vectashield medium (Vector Laboratories, Burlingame, CA) and
coverslipped. Mounted slides were observed with a confocal laser
scanning microscope (LSM 510; Zeiss, Thornwood, NY). Images
were acquired using 40 and 63 oil-immersion objectives withZeiss LSM software. Adobe Photoshop CS5 (Adobe Systems, San
Jose, CA) was then used to crop images and uniformly apply iden-
tical brightness and contrast adjustments.
3. Results
3.1. Effects of injected saline on the ERG
To control for possible artifactual effects of puncturing the eye
and injecting saline on the ERG, a set of control experiments
were conducted using exactly the same procedures in which ster-
ile saline was injected unilaterally (Fig. 1A). It was found that
injecting saline alone reduced the mean b-wave by 3–17% com-
paring to the uninjected control eyes depending on the strength
of stimulus (n = 8). Therefore, the subsequent results have been
normalized according to their corresponding stimulus strength
and recorded time to compensate for this saline attributed effect
such that:
normalized amplitudeLAP4 ¼
amplitudeLAP4 injected eye
amplitudeuninjected fellow eye
Mean amplitudeuninjected control eyes
Mean amplitudesaline injected eyes
To facilitate dissection of the rod/cone pathways the stimulus
strength is divided into four different zones (Abd-El-Barr, et al.,
2009), which correspond to the operating ranges of different
retinal neurons including rod, cone, DBCR, DBCC and AII amacrine
cells (Fig. 1B). For simplicity, zones I and II together may be
regarded as scotopic zones, while zone III and IV may be respec-
tively regarded as mesopic and photopic. In zone I, the positive
and negative scotopic threshold response (STR) originated from
third order neurons (Saszik, et al., 2002) are the only detectable
components of the ﬂash ERG. As stimulus strength increases, DBCRs
and DBCCs become functional in zone II and manifest as the char-
acteristic rod driven b-wave. The b-wave increases in amplitude as
the stimulus strength increases, and buries the positive STR which
may also exist in zone II. In zone III, the M-cone driven DBCs are
functional. Their electrical activities are added to the rod driven
b-wave from zone II. In zone IV, the M/S-cone becomes active as
well. The recorded ERG b-wave is a summation of the activities
of the M/S-cone driven DBCs and those from zone III.
3.2. Effects of glutamate analogue LAP4 on the ERG
Exogenously introduced LAP4 (a synthesized glutamate ana-
logue and a speciﬁc agonist for group III metabotropic glutamate
receptors) inhibited the ERG b-wave shortly after being injected.
As shown in Fig. 1C, such inhibition of the b-wave was most prom-
inent at the 5 min point and dissipated partially within the ﬁrst
hour after injection.
00.2
0.4
0.6
0.8
1
1.2
0 20 40 60
N
or
m
al
iz
ed
 B
-w
av
e 
am
pl
it
ud
e
Time (min)
25µM LAP4
-1.0
-0.2
0.1
0.6
1.2
1.8
2.3
4.8
6.2
C
A
B -2 -1 0 1 2 3 4 5 6 7 8
Rod
M cone
M/S-Cone
DBCR
DBCc
AIIAC
0.4
0.6
0.8
1
1.2
-2 -1 0 1 2 3 4 5 6 7 8
w
av
e 
am
pl
it
ud
e
(s
al
in
e 
in
je
ct
ed
 e
ye
s/
un
in
je
ct
ed
 c
on
tr
ol
 e
ye
s)
S mulus strength (log10 R*/rod)
Saline
Zone IIZone I Zone III Zone IV
100ms1
00
μV
BFellow
BFellow
BLAP4
BLAP4
50min
5min
n=8
Fig. 1. (A) Relative b-wave amplitude against stimulus strength, measured 5 min after injection of saline. B-wave was reduced by a maximum of 17% in stimulus zone II, and
about 3% in stimulus zone IV. This serves as a basis for normalization for the LAP4 or TBOA data. (B) Dynamic ranges (deﬁned as 5–95% of maximum response) of various
retinal neurons measured in wild type mice. Rod, M- and S-cone data are from suction-electrode recording from outer segments (Field & Rieke, 2002; Nikonov, et al., 2006).
M/S-cone range is extrapolated from the fact that many cones co-express both pigments (Applebury, et al., 2000). Ranges for DBCR, DBCC, and AIIAC are from light-evoked
voltage-clamp results (Pang, et al., 2004). (C) Changes of b-wave amplitude over time after applying 25 lM (retinal concentration) LAP4. Lines represent corresponding
strength of stimulus in log R*/Rod. Normalized b-wave amplitudes were lowest at the 5 min point and increased with time, implying that LAP4 inhibits the b-wave through a
fast acting mechanism. Representative wave traces at 5 min and 50 min are shown on the right.
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imental approach to establish its dose–response relationship.
Thirty-two mice were injected with various concentrations of the
agonist and then the ERG was used to monitor the effect of the
drug. The data at the 5 min time point at which inhibition was
maximum was chosen for the above purpose before the LAP4
was cleared from the synaptic cleft with time. The b-wave ampli-
tude was then plotted against the retinal concentration in Fig. 2
panels A–C according to the strength of stimulus. As read from
the drop-lines, LAP4 has IC50 values of 1.57, 0.32 and 0.65 log lM
(37, 2.1 and 4.5 lM) at stimulus strengths of 6.2, 1.8 and 0.1 log R*/Rod, respectively. The IC50, deﬁned as the concentration of the
drug that inhibits 50% of the measured response, was found to be
about 1 or more log unit higher in the photopic zone IV than those
in measured zone III and II.
The highest concentration tested was 3.7 log lM (5 mM). The
inhibitions leveled off at 3.1, 1.4 and 3.1 log lM at stimulus
strengths of 6.2, 1.8 and 0.1 log R*/Rod, respectively. The b-wave
was fully suppressible when measured with a zone III moderate
stimulus but not with zone II or IV stimuli. It is unlikely that the
LAP4 insensitive b-waves in zone II and IV were resulted from
inadequate LAP4 concentrations in the synapses, because b-wave
AB
C
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Fig. 2. Dose–response curves showing the amplitude of the b-wave against log
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points and error bars denote value mean and standard error respectively. Values in
black and green beside the vertical drop-lines represent IC50 and EC50, respec-
tively. (A) Dose–response curve measured with a strong rod-saturating zone IV
stimulus within the operating range of cones. B-wave was inhibited by 72% with
highest concentrations of LAP4. (B) Curve measured with a moderate zone III
stimulus. The b-wave was nearly fully inhibited (96%) when concentrations were
high enough. (C) Curve measured with a weaker zone II stimulus. The b-wave was
strongly inhibited by the highest concentrations of the drug, with about 15%
remaining. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
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than 1.4 log lM.
The residual ‘‘b-wave’’ in zone II may be attributed to a LAP4
insensitive component related to the positive STR, which arises
from third-order retinal cells, appears as positive wave form ofsimilar latency and could have been otherwise buried by the
b-wave. We have previously found a similar corneal positive
component resembling the positive STR in DBCRs-lacking
bhlhb4(/) mice when ERG was recorded using appropriate
stimuli after prolonged dark adaption. The residual b-wave in zone
IV is further studied in the result section associated with Fig. 7.
LAP4 inhibits the b-wave without consistently affecting the
a-wave. When the raw ERG wave form is examined, the inhibition
of the b-wave appeared to be associated with a minor change in
the amplitude of the a-wave in some of the mice (Fig. 3A and B).
The change in amplitude of the a-wave was different in individual
mice and was not so dose-dependent, as shown in Fig. 3C. Because
a-waves normally manifest as a PIII component truncated by a PII
component (Granit, 1933), LAP4 increased the variation of the
a-wave through suppressing the b-wave.
3.3. Effects of EAAT5 non-speciﬁc blocker (TBOA) on ERG
TBOA also inhibited the ERG b-wave shortly after it was
injected. As shown in Fig. 4A, the b-wave was strongly inhibited
with 200 lM TBOA at the 5 min post-injection time point, and
recovered progressively during the 1 h window measured for
stimuli of all intensities tested. Similar to the case of LAP4, the
amplitude of the a-wave was not systematically inhibited by TBOA
(Fig. 4B and C) despite an increase in variation. Thus, implying that
phototransduction was not inhibited.
To characterize the dose–response relationship between TBOA
and the inhibition of the b-wave, 32 mice were injected with
several different concentrations of TBOA and then ERG was used
to monitor the effect of the TBOA. Data at the 5 min time point
was chosen to plot the dose–response curves in Fig. 5 panels A–C
according to the strength of stimulus. As read from the drop-lines,
TBOA has IC50 values of 3.01, 1.37 and 1.95 log lM (1023, 23,
89 lM) at stimulus strengths of 6.2, 1.8 and 0.1 log R*/Rod, respec-
tively. Such values are higher than those of LAP4. TBOA fully inhib-
ited the b-wave in stimulus range of zone III and partially inhibited
the b-wave in zone II and IV. This pattern of inhibition is similar to
that of LAP4.
3.4. Effects of injecting EAAT5 inhibitor (TBOA) on bhlhb4/ mice
While it is known that the b-wave originates from retinal
depolarizing bipolar cells, those cells can be classiﬁed as rod
depolarizing bipolar cells (DBCR) and cone depolarizing bipolar
cells (DBCC). To determine whether TBOA inhibits the b-wave
through acting on the DBCCs, bhlhb4/ mice in which DBCRs
are genetically removed (Bramblett, et al., 2004), were injected
with either a low concentration of TBOA (0.5 lM, n = 7) or a high
concentration of TBOA (1 mM, n = 5). Bhlhb4/ mice are known
to have reduced baseline amplitudes of the b-wave in all intensity
zones (Abd-El-Barr, et al., 2009) due to the lack of DBCRs. As shown
in Fig. 6, 0.5 lM TBOA signiﬁcantly inhibited the b-wave up to
45–48% in zone III and IV. A higher concentration 1 mM TBOA
extended the inhibition to zone II, in addition to zones III and IV.
The fact that TBOA inhibited the b-wave in mice lacking DBCRs sug-
gests that b-waves generated by DBCCs are suppressible by TBOA.
Such inhibition can be mediated by a direct inhibition of postsyn-
aptic EAAT5 on DBCCs, or by indirectly abolishing the glutamate
buffering capacity of presynaptic EAATs and a resultant accumula-
tion of synaptic glutamate. Since 0.5 lM TBOA does not alter the
buffering capacity for glutamate (as shown in Section 3.3 of the
companion paper), its inhibition of the b-wave in zone III and IV
is best explained by the former mechanism. In contrast, inhibition
of the b-wave in zone II was found only when a high concentration
of TBOA was applied. This suggests that such inhibition was prob-
ably mediated by the latter mechanism. In light of the single cell
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when LAP4 concentrations were high. The slopes for the linear regression lines were 0.041, indicating that the amplitude of the a-wave barely changed with the
concentration.
68 D.Y. Tse et al. / Vision Research 103 (2014) 63–74dynamic range data (Fig. 1B), TBOA could have directly inhibited
the DBCCs driven by M-cones or M/S-cones, and indirectly inhib-
ited the DBCCs driven by rods.
3.5. Additional inhibitory effect of TBOA over saturated dose of LAP4
In Figs. 2, 5 and 6, we have shown that LAP4 or TBOA, when
injected alone, inhibited the b-wave strongly in stimulus zone III,
but partially in zone II and IV. We sought to test whether their
inhibitory effects are additive by co-injecting them in wild type
mice. ERG was then measured and compared to those of control
mice injected with a saturating dose of either LAP4 or TBOA
(5 mM and 4 mM respectively at the retina level). These concentra-
tions are known to produce maximum possible inhibition of the
b-wave as predicted by the dose–response curves constructed ear-
lier as Figs. 2B and 5A.
As shown in Fig. 7A zone IV, the saturating concentration of
5 mM LAP4 inhibited the mean b-wave amplitude by about 72%.
Mice injected with a slightly lower concentration of 1.25 mM
LAP4 in the presence of 0.5 mM co-injected TBOA produced a sig-
niﬁcantly stronger inhibition of 86–88% of the b-wave. This sug-
gests that the inhibition exerted by LAP4 and TBOA, to a certain
extent, are additive in this range of stimulus strength, where both
the rod and cone pathways contribute to the ERG.
The fact that the above additive nature takes place only in zone
IV may suggest a speciﬁc role for TBOA in the cone pathway. To test
this hypothesis, we repeated the above experiment using the samegrouping of animals but measured them with the double ﬂash ERG
protocol to isolate the cone driven response from that of rods. In
Fig. 7B, eyes injected with 5 mM LAP4 have a mean residual
b-wave amplitude of 42%. Eyes injected with TBOA or the mixture
have mean residual b-wave amplitudes of 12% and 6%, respec-
tively. In other words, TBOA, when injected alone or when
co-injected produced signiﬁcantly stronger inhibition of the
b-wave than solely injected LAP4. Since multiple subtypes of DBCC
and DBCR that directly receive input from cones are potentially
contributing to the measured cone-driven b-wave, our result
may indicate that some of the LAP4-insensitive DBCs were inhib-
ited by TBOA. Representative raw ERG traces resulting from the
second ﬂash (probe ﬂash) are shown in Fig. 7C. The small residual
b-wave following the application of LAP4 was abolished by
co-injection of TBOA, revealing the late portion of the negative
Granit PIII component (Granit, 1933) otherwise truncated by the
residual b-wave. Similar small residual b-waves in the photopic
range were sometimes regarded as oscillatory potentials in some
previous studies (Masu, et al., 1995), without considering that
the late PIII component should have become visible if b-wave
was fully suppressed, and that oscillatory potentials should have
manifested as a higher frequency component.
In human, the OFF-bipolar cell (HBCc) pathway has been
reported to constitute a signiﬁcant component of the cone-
dominated b-wave in single ﬂash ERG (Fitzgerald, et al., 1994).
Therefore, there is a possibility that the current TBOA inhibition
on the mouse cone-driven ERG b-wave was mediated through a
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Fig. 4. (A) Changes in b-wave amplitude over a 50 min period following injection of
200 lM (retinal concentration) TBOA. Lines represent corresponding stimulus
strengths. Normalized b-wave amplitudes were the lowest at the 5 min point and
increased with time, implying that TBOA inhibits the b-wave through a fast acting
and temporary mechanism. (B) Representative raw ERG traces measured from eyes
5 min after injecting with saline, 50 lM TBOA and 1 mM TBOA with a zone III
stimulus of 1.8 log R*/Rod. (C) Scatterplot showing the normalized amplitude of a-
wave versus log concentration of TBOA measured with a zone III stimulus of
1.8 log R*/Rod. The slope of the regression lines is 0.03, indicating that the
amplitude of the a-wave does not change with the concentration of TBOA.
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the b-wave was largely reduced by about 75%.
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and accumulation of endogenous glutamate in the photorecep-
tor-HBCc synapse. This hypothesis is refuted by the ﬁnding that
the cone-driven ERG b-wave does not contain a signiﬁcant HBCc
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70 D.Y. Tse et al. / Vision Research 103 (2014) 63–74component in mouse like it does in human. Blocking HBCCs using
injected CNQX, a AMPA/KA receptor antagonist, produced only a
minor inhibition and reduced the photopic b-wave to 90% of unin-
jected control (Smith, et al., 2013). Our unpublished data using
injected DNQX (another AMPA/KA receptor antagonist) have
shown a similar extent of minor inhibition of the cone driven
b-wave which was not different from that produced by injected
saline.increasing stimulus strength for wild type mice injected with saturating concen-
trations of LAP4 (n = 7), TBOA (n = 4), or a mixture of them (n = 6). Data points and
error bars represent mean and standard error, respectively. In stimulus zone II and
III, all three groups showed inhibition of the b-wave and there is no signiﬁcant
difference between them. In zone IV, eyes co-injected with LAP4 and TBOA showed
the smallest amplitude of b-wave, which is signiﬁcantly smaller than that in eyes
injected with either drug alone. (B) Isolated cone b-wave response measured using
a double ﬂash method for the same three groups of mice. Data again normalized to
saline control. Saturated dose of LAP4 inhibited cone b-wave by 58% compared to
that of saline control. TBOA, when injected alone, or when co-injected with LAP4
produced signiﬁcantly stronger inhibition, resulting in residual mean b-wave
amplitudes of 12% and 6% respectively. (C) Representative wave traces elicited by
the second (probe) ﬂash in the double ﬂash ERG. Traces shown were eyes injected
with saline, 1.25 mM LAP4, 5 mM LAP4 or a mixture of LAP4 and TBOA. The two
concentrations of LAP4 produced similar wave traces in which b-waves were
partially inhibited. In eyes injected with the mixture of drugs, the b-wave was
greatly diminished to become a small positive potential that failed to fully truncate
the PIII, which manifested as a negative potential after the small b-wave.3.6. Effects of co-injecting TBOA with GABA antagonists
It has been reported that some gamma-aminobutyric acid
(GABA)-ergic and glycinergic amacrine cells exert negative feed-
back on the axon terminals of bipolar cells (Tachibana & Kaneko,
1987, 1988b; Eggers, et al., 2007; Eggers & Lukasiewicz, 2011),
and that such feedback may shape, augment or suppress the ERG
b-wave (Awatramani, et al., 2001; Dong & Hare, 2002; Kapousta-
Bruneau, 2000). To determine whether TBOA inhibited the ERG
b-wave through the above GABA-ergic or glycinergic feedback
mechanisms, a cocktail of GABA and glycine receptor antagonists
was co-injected with TBOA into one eye of wild type mice to block
the feedback before ERG was measured. Antagonists used were
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Fig. 8. A plot of normalized b-wave amplitude for a range of increasing stimulus
strength for mice injected with a cocktail of GABA/glycine antagonists (n = 5), and
mice co-injected with 1 mM TBOA and the same cocktail (n = 5). Data points and
error bars represent mean and standard error, respectively. Dashed lines represent
boundaries between the II, III and IV zones of stimulus strength. Mice injected with
GABA antagonist cocktail alone have the b-wave inhibited by 50–65%. Mice co-
injected with the cocktail and TBOA have signiﬁcantly lower b-wave than the other
group in zone III and IV.
Fig. 9. (A–D) Confocal microscopic images of retina from wild-type mice processed
for EAAT5 (blue), PSD95 (green), and Goa (red) immunoﬂuorescence. The pictorial
legends on the right denote the sub-stratiﬁcation of the OPL into the distal (OPL-D)
and the proximal (OPL-P) layers. (A) EAAT5 staining was found throughout the
whole thickness of the OPL. (B) PSD95 staining was conﬁned mostly to the distal
half of the OPL where it co-localized with about half of the EAAT5 staining. This
indicates the presence of EAAT5 on the rod spherules, and also on some
postsynaptic structures. (C) Goa staining was observed intensely in the proximal
half of the OPL where it overlapped nicely with the EAAT5 staining pattern not
occupied by PSD95 staining. This indicates that EAAT5 is present on the dendritic
processes and somas of some bipolar cells. (D) A three channel merged view of the
above. (E–H) Confocal microscopic images of retina from bhlhb4/ mice
processed for EAAT5 (blue), PSD95 (green), Goa (red) immuno-ﬂuorescence
showing a segment of the OPL. (E) EAAT5 immuno-labeling was observed
throughout the whole thickness of the OPL. (F) PSD95 staining co-localized with
EAAT5 staining in the distal half while (G) Goa co-localized with EAAT5 in the
proximal half region. Since bhlhb4/ mice lack DBCR, the Goa staining here is
attributed to DBCC. (H) A merged image showing all three channels.
D.Y. Tse et al. / Vision Research 103 (2014) 63–74 711 lM strychnine, 100 lM bicuculline and 100 lM TPMPA (calcu-
lated retinal concentrations).
As shown in Fig. 8, blocking GABA-ergic and glycinergic feed-
back by injecting the antagonist cocktail partially inhibited the
b-wave. Injecting TBOA in the presence of GABA/glycine
antagonists produced stronger inhibition than injecting the antag-
onists alone. TBOA produced a similar pattern of inhibition regard-
less of whether it was injected alone (Fig. 7A) or was co-injected
with the antagonist cocktail (Fig. 8). These results indicate that
the mechanism through which TBOA suppresses the b-wave does
not rely on GABA-ergic or glycinergic negative feedbacks.3.7. Immunohistochemistry
To unravel the anatomical basis for the TBOA sensitivity of ERG
b-waves, a series of IHC experiments were performed to study the
expression of EAAT5 in retina. EAAT5 staining was found to be
present in the OPL as well as the ON and the OFF strata of the
IPL. We focused the subsequent experiments on the OPL because
the b-wave is generated by DBCs, and the OPL is where the DBCs
receive synaptic inputs from primary neurons. It is known that
the OPL contains processes from ﬁve types of neurons including
rod axon terminals, cone axon terminals, DBCR dendrites, DBCC
dendrites, and horizontal cell processes and their somas. Thus a
combination of antibodies was used and advantage was taken of
the bhlhb4/ mice that lack DBCRs.
Fig. 9A shows that EAAT5 is present throughout the whole
thickness of the OPL. Fig. 9B shows that EAAT5 is present on the
rod spherules; and Fig. 9C and D shows that EAAT5 is present on
the dendritic processes of DBCs (DBCR or DBCC) in wild type mice.
Using the bhlhb4/ mice, it is shown that EAAT5 is also present
throughout the entire OPL (Fig. 9E), on the rod spherules (Fig. 9F)
and on the dendritic process of DBCCs (Fig. 9G and H). EAAT5
was not observed on the active zones of cone pedicles (Fig. 10A),
but on the active zones of DBC dendrites synapsing with the ped-
icles (Fig. 10B and C). Horizontal cells appeared to be negative
for EAAT5 (Fig. 10D–G). In contrast, some DBCRs in the wild type
retina were found to express EAAT5 on their dendritic processes,
at least extrajunctionally (Fig. 10H–K).4. Discussion
In the present study, we took advantage of an infrared illumi-
nated microinjection system to study the effect of TBOA and
LAP4 on the ERG of dark-adapted mice. We found that TBOA and
the glutamate analogue LAP4 shared a similar time course for
inhibiting the ERG b-wave. The IC50 value for TBOA inhibition of
the b-wave was found to be 23.4 lM (1.37 log lM), which is about
1 log unit higher than that of LAP4 in stimulus zone III. Our data
also showed that the TBOA induced inhibition of b-waves in
bhlhb4/ mice was most prominent in zones III and IV, where
M-cones and M/S cones are actively driving DBCCs. More interest-
ingly, the data suggested that TBOA associated inhibition and LAP4
associated inhibition were somewhat additive in the strongest
stimulus zone IV, where the b-wave is comprised of a cone-driven
response in addition to a rod-driven response. Additionally, TBOA
alone, compared to LAP4, produced a stronger inhibition of the iso-
lated cone-driven b-wave measured using a double ﬂash protocol.
Similar inhibition was not observed when EAAT1 or EAAT2 block-
ers were injected (as shown in Section 3.2 of the companion
paper). The above electrophysiological data suggest a signiﬁcant
role for EAAT5 in mediating cone-driven bipolar cell light
responses, and perhaps a minor role in mediating rod-driven bipo-
lar cell light responses. By comparing with the effect of injecting
GABA-ergic and glycinergic antagonists, we have shown that TBOA
mediated inhibition of the b-wave uses a mechanism different
from the negative feedback from amacrine cells. Our IHC data indi-
cated the presence of postsynaptic EAAT5 on some DBCCs, and
probably on some DBCRs, providing a possible anatomical basis
for its role on the b-wave.
Fig. 10. (A–C) Confocal microscopic images of retina from wild-type mice
processed for EAAT5 (red), PNA (blue), and Goa (green) immunoﬂuorescence. (A)
EAAT5 staining did not overlap with PNA staining but was present on the structure
above it, suggesting that EAAT5 is not present on the active zones (arrows) of cone
pedicles but is present extrajunctionally on the terminal. (B) Introducing the Goa
green channel helped identify cone-bipolar synapses (arrows), one of which
(bracketed) is further magniﬁed in panel (C). (C) A bipolar cell (green) making a
synapse with a cone pedicle labeled in blue. Red EAAT5 co-localized with the green
Goa on the bipolar cell dendrites results in the yellowish patches immediately
below the cone pedicle, suggesting that EAAT5 is present on the DBCC active zone
postsynaptically. (D–G) A z-axis image series showing consecutive optical sections
(1 lm apart) of wild type retina processed for Calbindin (green) and EAAT5 (red)
immunoﬂuorescence. Calbindin staining showed minimal overlapping with that of
EAAT5, implying that EAAT5 does not express on horizontal cells. (H–K) Similar
image series from wild type retina processed for PKCa (green) and EAAT5 (red)
immunoﬂuorescence. EAAT5 labeling co-localized with that of PKCa, resulting in
yellow color on the dendritic processes of some DBCRs. Such EAAT5 immuno-
labeling is stronger on some DBCRs (arrows) than others. It is difﬁcult to determine
whether the EAAT5 is present junctionally on the dendrites, which extended to the
distant half of the OPL and invaginated the rod spherules.
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Apart from those lower vertebrates reviewed earlier, EAAT5 has
been found in retinae of several mammals, mostly located
presynaptically. It has been reported on the terminals of rods,
DBCCs and DBCRs in rat (Pow & Barnett, 2000), rods and DBCCs in
cat (Fyk-Kolodziej, et al., 2004), rods in rabbit and macaque
(Pow, et al., 2000), and terminals of rods, cones, DBCRs and HBCs
in mouse (Cheng, et al., 2012; Hasegawa, et al., 2006; Wersinger,
et al., 2006).
Using IHC double labeling, the present study conﬁrms the
single labeling morphology-based observation of an earlier study
that EAAT5 is present on mouse rod spherules, but suggested that
its presence on mouse cone pedicles is not junctional but
extrajunctional.
The present study is the ﬁrst to report postsynaptic EAAT5 on
mice DBCCs and some DBCRs. Wersinger, et al. (2006) detected a
small TBOA-sensitive current when glutamate was puffed on DBCR
dendrites and did not study it further. Hasegawa, et al. (2006),however, did not ﬁnd such a current in their similar experiment
on DBCRs. Since our IHC result indicates that some DBCRs express
more EAAT5 than others on their dendritic processes, this may
be one of the reasons why previous studies have had limited
success in detecting them with a small sample size. Another possi-
bility could be that the invaginated shape of the rod-DBCR synapse
acted as a diffusion barrier for the puffed glutamate and prevented
it from reaching postsynaptic EAAT5 on the DBCR in a timely
manner.
4.2. Possible mechanism of light response mediated by EAAT5
In darkness, endogenous GLU is continuously released from
photoreceptor terminals, resulting in a high concentration of GLU
in the synaptic cleft. The extracellular GLU binds to mGluR6 on
DBCs and closes the gated cation channel, which contributes to
the tonic hyperpolarization in DBCs. The extracellular GLU also
binds to EAAT5 and opens the chloride channel (Grant &
Dowling, 1995), which allows Cl to enter the cell down its concen-
tration gradient and also contributes to tonic hyperpolarization in
DBCs. Exposure to light stops endogenous GLU release and reverses
the above processes, causing the DBC to depolarize. The swift
change from a hyperpolarized state to a depolarized state in DBCs
causes a corneal-positive potential, truncating the corneal-
negative a-wave and manifests as the b-wave.
Exogenously applied GLU analogue LAP4 keeps the mGluR6
occupied regardless of light, precluding the cation channel from
opening and the DBC from depolarizing, thus effectively inhibiting
the light response.
It is not surprising that injected TBOA above a certain concen-
tration would block pre-synaptic EAATs or EAAT1 on the Müller
cells, leading to an accumulation of GLU in the synaptic cleft and
subsequently inhibit the b-wave in a way similar to that when
exogenous GLU is injected. We have studied this phenomenon in
our companion paper and found that TBOA inhibited the b-wave
at a low concentration (0.5 lM) at which the GLU buffering/remov-
ing capacity of pre-synaptic/Müller EAATs was unaffected (no
effect on the GLU dose–response curve). Given that the same
0.5 lM concentration of TBOA signiﬁcantly inhibited the residual
b-wave in Bhlhb4 KO mice (Fig. 6B), it is indicated that TBOA at
low concentration inhibits the b-wave by acting on the postsynap-
tic EAAT5 instead of presynaptic/Müller EAATs.
In darkness, GLU opens EAAT5 coupled Cl channels on DBC
dendrites resulting in an inﬂux of Cl that hyperpolarizes DBCs.
Light closes the Cl channels, suppresses Cl inﬂux and depolarizes
DBCs. We propose that TBOA blocks the EAAT5-coupled Cl chan-
nels in darkness, abolishes their contribution to the hyperpolarized
state of the cell, and suppresses light-induced depolarization. Such
a mechanism takes place at a low TBOA concentration, without
signiﬁcantly affecting the re-uptake process of synaptic GLU by
presynaptic EAATs.
4.3. Possible physiological function
Traditionally, the transporter function of EAAT5 has received
more attention than its ligand gated channel function (Sonders
& Amara, 1996). More recently, multiple splice variants of EAAT5
have been reported and it is predicted that some of those EAAT5
isoforms possess one of the above functions while some possess
the other (Lee, et al., 2012). There are multiple subtypes of DBCC
and DBCR as classiﬁed by their morphology and photoreceptor
input (Ghosh, et al., 2004; Pang, et al., 2010) in mouse. It is yet
to be elucidated which DBC subtypes adopt the mGluR6 mecha-
nism, the EAAT5 mechanism or a combination of them. Our IHC
data has shown that the EAAT5 machinery is present on the den-
dritic processes of some DBCCs and DBCRs. Performing single cell
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task. The current ERG study has provided tools to screen for the
functional EAAT5 mechanism, provided resolving power to
dissect the underlying rod/cone pathway and is an important
step for future studies. In light of our data, it is likely that EAAT5
plays a role in mediating ON-light responses of some DBCs driven
by cones. Other DBCs may either possess only the mGluR6
machinery, or possess both mGluR6 and EAAT5 machineries
but have their light response dominated by the mGluR6
mechanism.
It remains unclear why the retina needs two different signaling
mechanisms for the On-light response of DBCs. Intuitively, the two
mechanisms may coexist as some form of parallel processing. Their
differences in sensitivity, dynamics or operating range may also
enable them to serve different functions, in a manner similar to
the differential roles of NMDA, AMPA and kainate ionotropic
receptors that coexist on dendrites of some neurons. The EAAT5
mechanism may also provide some resiliency to retinal signal
processing by acting as a backup and limit the degradation of
visual functions when the mGluR6 mechanism fails, as exempliﬁed
by the cases of human mGluR6-deﬁcient night blindness (Dryja,
et al., 2005).
Another possible physiological function of EAAT5 on DBCs is
importing Cl at DBC dendrites and maintaining a high dendritic
[Cl]. A high dendritic [Cl], which makes the chloride reversal
potential Ecl > resting potential ER, is postulated to be critical for
horizontal cells to depolarize DBCs through GABA (Miller &
Dacheux, 1983; Vardi & Sterling, 1994). Recent work using two-
photon imaging has proved the existence of a higher dendritic
[Cl] over somatic [Cl] in DBCs, and shown that this gradient
was largely preserved after the application of blockers for Na–K–
Cl cotransporter (NKCC) and K–Cl co-transporter (KCC) (Duebel,
et al., 2006). This suggests that the remaining [Cl] gradient
requires an additional transport system, which is not NKCC
(Zhang, et al., 2007) but could potentially be the EAAT5 chloride
channels on DBC dendrites.
4.4. Conclusion
The present study has provided electrophysiological evidence
that suggest a signiﬁcant role for EAAT5 in mediating cone-driven
bipolar cell light responses, and perhaps a peripheral role in medi-
ating rod-driven bipolar cell light responses. Our IHC data indi-
cated the presence of postsynaptic EAAT5 on some DBCCs, and
probably on some DBCRs. These provides an anatomical basis for
its role on the ERG b-wave and probably on the maintenance of a
high chloride concentration at DBCs dendrites.
Grants
This work was supported by NIH EY004446 & EY019908, NIH
Vision Core EY02520, the Retina Research Foundation (Houston),
Research to Prevent Blindness Inc, and the International Retinal
Research Foundation Loris and David Rich Postdoctoral Scholar
Award.
Disclosures
No conﬂicts of interest, ﬁnancial or otherwise, are declared by
the authors.
Author contributions
D.Y.T and I.C. participated in designing the experiment, collect-
ing and analyzing the data, and writing the article. S.M.W. wasinvolved in designing the experiment, interpreting the data, and
writing the article.Acknowledgments
We thank J.J. Pang and I. Fahrenfort for suggestions and
comments, Z. Yang for technical support, R. Jacoby for carefully
reading manuscript and helpful comments.References
Abd-El-Barr, M. M., Pennesi, M. E., Saszik, S. M., Barrow, A. J., Lem, J., Bramblett, D. E.,
et al. (2009). Genetic dissection of rod and cone pathways in the dark-adapted
mouse retina. Journal of Neurophysiology, 102(3), 1945–1955.
Applebury, M. L., Antoch, M. P., Baxter, L. C., Chun, L. L., Falk, J. D., Farhangfar, F.,
et al. (2000). The murine cone photoreceptor: A single cone type expresses both
S and M opsins with retinal spatial patterning. Neuron, 27(3), 513–523.
Arriza, J. L., Eliasof, S., Kavanaugh, M. P., & Amara, S. G. (1997). Excitatory amino acid
transporter 5, a retinal glutamate transporter coupled to a chloride
conductance. Proceedings of the National Academy of Sciences of the United
States of America, 94(8), 4155–4160.
Attwell, D. (1990). The photoreceptor output synapse. In N. Osborne & G. Chader
(Eds.). Progress in retinal research (Vol. 9, pp. 337–362). Oxford: Pergamon Press.
Awatramani, G., Wang, J., Slaughter, M. M., et al. (2001). Amacrine and ganglion cell
contributions to the electroretinogram in amphibian retina. Visual Neuroscience,
18(1), 147–156.
Blanks, J. C., & Johnson, L. V. (1983). Selective lectin binding of the developing
mouse retina. The Journal of Comparative Neurology, 221(1), 31–41.
Bramblett, D. E., Pennesi, M. E., Wu, S. M., & Tsai, M. J. (2004). The transcription
factor Bhlhb4 is required for rod bipolar cell maturation. Neuron, 43(6),
779–793.
Cervetto, L., & MacNichol, E. F. Jr., (1972). Inactivation of horizontal cells in turtle
retina by glutamate and aspartate. Science, 178(4062), 767–768.
Cheng, C. L., Djajadi, H., & Molday, R. S. (2012). Cell-speciﬁc markers for the
identiﬁcation of retinal cells by immunoﬂuorescence microscopy. T Retinal
Degeneration, 935, 185–199.
Copenhagen, D. R., & Jahr, C. E. (1989). Release of endogenous excitatory amino
acids from turtle photoreceptors. Nature, 341(6242), 536–539.
Danbolt, N. C. (2001). Glutamate uptake. Progress in Neurobiology, 65(1), 1–105.
de Melo, J., Qiu, X., Du, G., Cristante, L., & Eisenstat, D. D. (2003). Dlx1, Dlx2, Pax6,
Brn3b, and Chx10 homeobox gene expression deﬁnes the retinal ganglion and
inner nuclear layers of the developing and adult mouse retina. The Journal of
Comparative Neurology, 461(2), 187–204.
Dong, C. J., & Hare, W. A. (2002). GABAc feedback pathway modulates the amplitude
and kinetics of ERG b-wave in a mammalian retina in vivo. Vision Research,
42(9), 1081–1087.
Dryja, T. P., McGee, T. L., Berson, E. L., Fishman, G. A., Sandberg, M. A., Alexander, K.
R., et al. (2005). Night blindness and abnormal cone electroretinogram ON
responses in patients with mutations in the GRM6 gene encoding mGluR6.
Proceedings of the National Academy of Sciences of the United States of America,
102(13), 4884–4889.
Duebel, J., Haverkamp, S., Schleich, W., Feng, G., Augustine, G. J., Kuner, T., et al.
(2006). Two-photon imaging reveals somatodendritic chloride gradient in
retinal ON-type bipolar cells expressing the biosensor Clomeleon. Neuron, 49(1),
81–94.
Eggers, E. D., & Lukasiewicz, P. D. (2011). Multiple pathways of inhibition shape
bipolar cell responses in the retina. Visual Neuroscience, 28(1), 95–108.
Eggers, E. D., McCall, M. A., & Lukasiewicz, P. D. (2007). Presynaptic inhibition
differentially shapes transmission in distinct circuits in the mouse retina. The
Journal of Physiology, 582(Pt 2), 569–582.
Field, G. D., & Rieke, F. (2002). Nonlinear signal transfer from mouse rods to bipolar
cells and implications for visual sensitivity. Neuron, 34(5), 773–785.
Fitzgerald, K. M., Cibis, G. W., Giambrone, S. A., & Harris, D. J. (1994). Retinal signal
transmission in Duchenne muscular dystrophy: Evidence for dysfunction in the
photoreceptor/depolarizing bipolar cell pathway. The Journal of Clinical
Investigation, 93(6), 2425–2430.
Fyk-Kolodziej, B., Qin, P., Dzhagaryan, A., & Pourcho, R. G. (2004). Differential
cellular and subcellular distribution of glutamate transporters in the cat retina.
Visual Neuroscience, 21(4), 551–565.
Ghosh, K. K., Bujan, S., Haverkamp, S., Feigenspan, A., & Wassle, H. (2004). Types of
bipolar cells in the mouse retina. The Journal of Comparative Neurology, 469(1),
70–82.
Granit, R. (1933). The components of the retinal action potential in mammals and
their relation to the discharge in the optic nerve. The Journal of Physiology, 77(3),
207–239.
Grant, G. B., & Dowling, J. E. (1995). A glutamate-activated chloride current in cone-
driven ON bipolar cells of the white perch retina. The Journal of Neuroscience:
The Ofﬁcial Journal of the Society for Neuroscience, 15(5 Pt 2), 3852–3862.
Grant, G. B., & Dowling, J. E. (1996). On bipolar cell responses in the teleost retina
are generated by two distinct mechanisms. Journal of Neurophysiology, 76(6),
3842–3849.
74 D.Y. Tse et al. / Vision Research 103 (2014) 63–74Grant, G. B., & Werblin, F. S. (1996). A glutamate-elicited chloride current with
transporter-like properties in rod photoreceptors of the tiger salamander. Visual
Neuroscience, 13(1), 135–144.
Hasegawa, J., Obara, T., Tanaka, K., & Tachibana, M. (2006). High-density presynaptic
transporters are required for glutamate removal from the ﬁrst visual synapse.
Neuron, 50(1), 63–74.
Haverkamp, S., & Wassle, H. (2000). Immunocytochemical analysis of the mouse
retina. The Journal of Comparative Neurology, 424(1), 1–23.
Kapousta-Bruneau, N. V. (2000). Opposite effects of GABA(A) and GABA(C) receptor
antagonists on the b-wave of ERG recorded from the isolated rat retina. Vision
Research, 40(13), 1653–1665.
Lee, A., Anderson, A. R., Barnett, N. L., Stevens, M. G., & Pow, D. V. (2012). Alternate
splicing and expression of the glutamate transporter EAAT5 in the rat retina.
Gene, 506(2), 283–288.
Lyubarsky, A. L., Daniele, L. L., & Pugh, E. N. Jr., (2004). From candelas to
photoisomerizations in the mouse eye by rhodopsin bleaching in situ and the
light-rearing dependence of the major components of the mouse ERG. Vision
Research, 44(28), 3235–3251.
Massey, S. C. (1990). Cell types using glutamate as a neurotransmitter in the
vertebrate retina. In N. Osborne & G. Chader (Eds.). Progress in retinal research
(Vol. 9, pp. 399–425). Oxford: Pergamon Press.
Massey, S. C., & Redburn, D. A. (1987). Transmitter circuits in the vertebrate retina.
Progress in Neurobiology, 28(1), 55–96.
Masu, M., Iwakabe, H., Tagawa, Y., Miyoshi, T., Yamashita, M., Fukuda, Y., et al.
(1995). Speciﬁc deﬁcit of the ON response in visual transmission by targeted
disruption of the mGluR6 gene. Cell, 80(5), 757–765.
Miller, R. F., & Dacheux, R. F. (1983). Intracellular chloride in retinal neurons:
Measurement and meaning. Vision Research, 23(4), 399–411.
Murakami, M., Otsuka, T., & Shimazaki, H. (1975). Effects of aspartate and glutamate
on the bipolar cells in the carp retina. Vision Research, 15(3), 456–458.
Nakajima, Y., Iwakabe, H., Akazawa, C., Nawa, H., Shigemoto, R., Mizuno, N., et al.
(1993). Molecular characterization of a novel retinal metabotropic glutamate
receptor mGluR6 with a high agonist selectivity for L-2-amino-4-
phosphonobutyrate. The Journal of Biological Chemistry, 268(16), 11868–11873.
Nelson, R. F., & Singla, N. (2009). A spectral model for signal elements isolated from
zebraﬁsh photopic electroretinogram. Visual Neuroscience, 26(4), 349–363.
Nikonov, S. S., Kholodenko, R., Lem, J., & Pugh, E. N. Jr., (2006). Physiological features
of the S- and M-cone photoreceptors of wild-type mice from single-cell
recordings. The Journal of General Physiology, 127(4), 359–374.
Oh, E. C., Khan, N., Novelli, E., Khanna, H., Strettoi, E., & Swaroop, A. (2007).
Transformation of cone precursors to functional rod photoreceptors by bZIP
transcription factor NRL. Proceedings of the National Academy of Sciences of the
United States of America, 104(5), 1679–1684.
Pang, J. J., Gao, F., & Wu, S. M. (2004). Light-evoked current responses in rod bipolar
cells, cone depolarizing bipolar cells and AII amacrine cells in dark-adapted
mouse retina. The Journal of Physiology, 558(Pt 3), 897–912.
Pang, J. J., Gao, F., Lem, J., Bramblett, D. E., Paul, D. L., & Wu, S. M. (2010). Direct rod
input to cone BCs and direct cone input to rod BCs challenge the traditional
view of mammalian BC circuitry. Proceedings of the National Academy of Sciences
of the United States of America, 107(1), 395–400.Pow, D. V., & Barnett, N. L. (2000). Developmental expression of excitatory amino
acid transporter 5: A photoreceptor and bipolar cell glutamate transporter in rat
retina. Neuroscience Letters, 280(1), 21–24.
Pow, D. V., Barnett, N. L., & Penfold, P. (2000). Are neuronal transporters relevant in
retinal glutamate homeostasis? Neurochemistry International, 37(2–3), 191–198.
Sarantis, M., Everett, K., & Attwell, D. (1988). A presynaptic action of glutamate at
the cone output synapse. Nature, 332(6163), 451–453.
Saszik, S. M., Robson, J. G., & Frishman, L. J. (2002). The scotopic threshold response
of the dark-adapted electroretinogram of the mouse. The Journal of Physiology,
543(Pt 3), 899–916.
Shigeri, Y., Seal, R. P., & Shimamoto, K. (2004). Molecular pharmacology of
glutamate transporters, EAATs and VGLUTs. Brain Research. Brain Research
Reviews, 45(3), 250–265.
Smith, B. J., Tremblay, F., & Cote, P. D. (2013). Voltage-gated sodium channels
contribute to the b-wave of the rodent electroretinogram by mediating input to
rod bipolar cell GABA receptors. Experimental Eye Research.
Sonders, M. S., & Amara, S. G. (1996). Channels in transporters. Current Opinion in
Neurobiology, 6(3), 294–302.
Szmajda, B. A., & Devries, S. H. (2011). Glutamate spillover between mammalian
cone photoreceptors. The Journal of Neuroscience: The Ofﬁcial Journal of the
Society for Neuroscience, 31(38), 13431–13441.
Tachibana, M., & Kaneko, A. (1987). Gamma-aminobutyric acid exerts a local
inhibitory action on the axon terminal of bipolar cells: Evidence for negative
feedback from amacrine cells. Proceedings of the National Academy of Sciences of
the United States of America, 84(10), 3501–3505.
Tachibana, M., & Kaneko, A. (1988a). L-glutamate-induced depolarization in solitary
photoreceptors: A process that may contribute to the interaction between
photoreceptors in situ. Proceedings of the National Academy of Sciences of the
United States of America, 85(14), 5315–5319.
Tachibana, M., & Kaneko, A. (1988b). Retinal bipolar cells receive negative feedback
input from GABAergic amacrine cells. Visual Neuroscience, 1(3), 297–305.
Vardi, N., & Sterling, P. (1994). Subcellular localization of GABAA receptor on bipolar
cells in macaque and human retina. Vision Research, 34(10), 1235–1246.
Wadiche, J. I., Amara, S. G., & Kavanaugh, M. P. (1995). Ion ﬂuxes associated with
excitatory amino acid transport. Neuron, 15(3), 721–728.
Wersinger, E., Schwab, Y., Sahel, J. A., Rendon, A., Pow, D. V., Picaud, S., et al. (2006).
The glutamate transporter EAAT5 works as a presynaptic receptor in mouse rod
bipolar cells. The Journal of Physiology, 577(Pt 1), 221–234.
Wong, K. Y., Adolph, A. R., & Dowling, J. E. (2005a). Retinal bipolar cell input
mechanisms in giant danio. I. Electroretinographic analysis. Journal of
Neurophysiology, 93(1), 84–93.
Wong, K. Y., Cohen, E. D., & Dowling, J. E. (2005b). Retinal bipolar cell input
mechanisms in giant danio. II. Patch-clamp analysis of on bipolar cells. Journal
of Neurophysiology, 93(1), 94–107.
Zhang, L. L., Delpire, E., & Vardi, N. (2007). NKCC1 does not accumulate chloride in
developing retinal neurons. Journal of Neurophysiology, 98(1), 266–277.
Zhang, J., Yang, Z., & Wu, S. M. (2005). Development of cholinergic amacrine cells is
visual activity-dependent in the postnatal mouse retina. The Journal of
Comparative Neurology, 484(3), 331–343.
